Family of woman who died of cervical cancer settle case against HSE and testing laboratory

As part of the settlement a letter of regret from the HSE to Gertrude Anne O’Beirne, who died in 2024, was read out in court
The court heard that experts on the family’s side raised an issue with nine of Gertrude Anne O’Beirne's smear tests but the focus of the case was on Ms O’Beirne’s last two smear tests in 2020 and 2021. File picture

The court heard that experts on the family’s side raised an issue with nine of Gertrude Anne O’Beirne's smear tests but the focus of the case was on Ms O’Beirne’s last two smear tests in 2020 and 2021. File picture

The family of a 75-year-old woman who died of cervical cancer have settled a High Court action against the HSE and a testing laboratory over her death.

Mother of three and grandmother to five, Gertrude Anne O’Beirne had initially taken the action herself but her daughter took over the proceedings after her mother died days after she brought the case. 

Gertrude Anne O’Beirne from Elphin, Co Roscommon, died on October 1, 2024.

In the proceedings against the HSE and the laboratory Quest Diagnostics Incorporated, it was claimed that two smear tests taken in December 2020 and December 2021 were allegedly misreported.

As part of the settlement a letter of regret from the HSE was read to the court. The letter from the chief executive of the National Screening Service, Fiona Murphy, expressed “sincere regret“ to Ms O’Beirne’s family on her death.

It added: “We wish to extend our deepest sympathies on your loss and do not underestimate how difficult a time this has been for you all.” 

Smear tests

The family’s counsel, Patrick Treacy SC instructed by Cian O’Carroll solicitors, told the court that Ms O’Beirne had a history of 16 different cervical smear tests taken between July 2009 and 2021.

He said experts on their side raised an issue with nine of those smear tests but the focus of the case was on Ms O’Beirne’s last two smear tests in 2020 and 2021.

Counsel said it was their case that the two smear tests were allegedly misread and experts would say that if the December 2020 smear test had been correctly reported early stage cervical cancer would have been detected and could have been successfully treated.

He said in relation to the 2021 cervical smear, it was their case if it had been correctly reported it is likely invasive cancer would have been detected.

Counsel said there was a question mark over nine of the smear tests but the case was based on two smear tests in 2020 and 2021.

Ms O’Beirne was diagnosed with Stage 3C cervical cancer in October 2023 and she underwent chemotherapy, radiotherapy and brachytherapy. 

In August 2024, she was diagnosed with advanced metastatic cervical cancer. She was moved to palliative care and she died on October 1, 2024.

Ms O’Beirne’s daughter, Lisa Wehrley from Sandymount, Dublin, had sued the HSE which is responsible for the CervicalCheck screening programme and the testing laboratory Quest Diagnostics Incorporated which tested Ms O'Beirne's smear samples.

Family's claims

In the proceedings, it was claimed that Ms O’Beirne had been allegedly deprived of the opportunity of timely and effective investigation and management of her condition. 

It was further claimed that she had been allegedly deprived of the opportunity of treatment at a time when her disease was amenable to curative treatment.

It was also contended that Ms O’Beirne’s cancer had been allegedly allowed to develop and spread unidentified, unmonitored and untreated until she was diagnosed with metastatic cervical cancer in 2023.

All of the claims were denied.

Noting the settlement and the division of the €35,000 statutory mental distress payment, Mr Justice Paul Coffey extended his deepest sympathy to Ms O’Beirne’s family.

More in this section

Lunchtime News

Newsletter

Get a lunch briefing straight to your inbox at noon daily. Also be the first to know with our occasional Breaking News emails.

Cookie Policy Privacy Policy Brand Safety FAQ Help Contact Us Terms and Conditions

© Examiner Echo Group Limited